SBUX Bets on Refreshers to Boost Afternoon Traffic: Will it Pay Off?
Source: zacks.com

Starbucks' U.S. comparable sales rose 7.9% in fiscal Q3 2026, driven by 4.2% transaction growth and a 3.6% increase in average ticket, while Refresher revenue grew at a double-digit year-over-year rate. The company is using Energy Refreshers, blended variants and planned sparkling Spritzers to expand afternoon traffic, though Dutch Bros and McDonald's are increasing competition in cold customizable beverages. SBUX has gained 21.2% over the past year, trades at a 32.04x forward P/E versus 21.49x for the industry, and consensus fiscal 2026 EPS forecasts imply 21.6% growth.
Analysis
The investable question is not whether afternoon beverages can add sales, but whether incremental visits are genuinely accretive after labor complexity, promotional spend and cannibalization of higher-margin morning demand. SBUX already embeds a demanding earnings recovery in its premium multiple; the market will require evidence that afternoon traffic raises store-level throughput without extending peak-period labor or sacrificing ticket. A sustained mix shift toward customized cold beverages could be margin-positive given ingredient economics, but food attachment and discount intensity will determine the net contribution.
BROS is the more direct competitive read-through: its drive-thru format, younger demographic and beverage-centric operating model leave it structurally better positioned to monetize incremental cold-drink occasions, while SBUX must alter entrenched customer behavior. MCD is less likely to win premium customization but can cap category pricing through value-led beverage bundles, creating a three-way squeeze on SBUX's pricing power. The key 1-3 month catalyst is weekly transaction commentary and app/order data around seasonal launches; product novelty alone is not a durable comp-sales driver.
Contrarian view: the apparent success may be partly category substitution rather than incremental consumption. If SBUX's afternoon gains primarily come from energy-drink and fast-food beverage share, BROS traffic or MCD beverage mix should weaken; absent that evidence, the category is likely expanding and the competitive concern is overstated. For the 6-18 month case, repeat purchase frequency, loyalty-member afternoon penetration and beverage attach rates matter more than initial launch sales; a failure to convert trial into repeat would expose an expensive SBUX earnings multiple to de-rating.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
Key Decisions for Investors
- Do not add directional SBUX exposure on this product-news signal alone. Maintain a neutral-to-underweight bias over the next 1-3 months unless management demonstrates sustained afternoon transaction acceleration with stable restaurant-level margins; a miss on traffic or incremental labor pressure is the clearest falsifier.
- Prefer BROS over SBUX as the higher-beta expression of cold/customized beverage demand over 6-12 months, but enter only on a pullback or after confirming same-store sales and new-store productivity. Thesis fails if BROS' transaction growth decelerates while beverage-category demand remains healthy, implying SBUX is taking share.
- For a market-neutral 3-6 month relative-value trade, consider long BROS / short SBUX only after the next comparable quarterly updates confirm BROS traffic resilience and SBUX's afternoon sales require elevated promotions. Size modestly: SBUX's valuation premium can persist if margins recover faster than expected.
- Monitor MCD beverage promotions and U.S. franchisee margin commentary. Broad value beverage discounting would be a negative second-order signal for SBUX pricing and a reason to increase the SBUX underweight; lack of discounting would support the view that premium beverage demand is incremental rather than share-destructive.
More News
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
- How Canadians are bracing for the impact of Trump’s trade war
- Rising petrol costs drive sharp inflation increase in US in August